nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2010-14-1-104-110nefr-1212Research ArticleНАБЛЮДЕНИЯ ИЗ ПРАКТИКИPRACTICAL NOTESБЫСТРОПРОГРЕССИРУЮЩИЙ НЕФРИТИЧЕСКИЙ СИНДРОМ У ПАЦИЕНТКИ С КРИОГЛОБУЛИНЕМИЧЕСКИМ ВАСКУЛИТОМ, АССОЦИИРОВАННЫМ С ХРОНИЧЕСКИМ ВИРУСНЫМ ГЕПАТИТОМ СRAPIDLY PROGRESSIVE NEPHRITIC SYNDROME IN PATIENTS WITH CRYOGLOBULINEMIC VASCULITIS ASSOCIATED WITH CHRONIC HEPATITIS CСмирновА. В.SmirnovA. V.

Кафедра пропедевтики внутренних болезней,

Научно-исследовательский  институт нефрологии.

ТрофименкоИ. И.TrofimenkoI. I.

Кафедра пропедевтики внутренних болезней

197022, Санкт-Петербург, ул. Льва Толстого, д.17, СПбГМУ им. акад И.П. Павлова, кафедра пропедевтики внутренних болезней. Тел. (812)-2340165; факс. (812)-2349563.

it@nephrolog.ruШумилинаА. А.ShumilinaA. A.

Кафедра пропедевтики внутренних болезней

ИвановО. И.IvanovO. I.

Кафедра пропедевтики внутренних болезней

СиповскийВ. Г.SipovskyV. G.

Научно-исследовательский институт нефрологии

ТитоваВ. А.TitovaV. A.

Научно-исследовательский институт нефрологии

ЗверьковР. В.ZverkovR. V.

Научно-исследовательский институт нефрологии

Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаRussian Federation201010012010141104110Copyright © Смирнов А.В., Трофименко И.И., Шумилина А.А., Иванов О.И., Сиповский В.Г., Титова В.А., Зверьков Р.В., 20102010Смирнов А.В., Трофименко И.И., Шумилина А.А., Иванов О.И., Сиповский В.Г., Титова В.А., Зверьков Р.В.Smirnov A.V., Trofimenko I.I., Shumilina A.A., Ivanov O.I., Sipovsky V.G., Titova V.A., Zverkov R.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/1212

.

.

криоглобулинемический васкулитбыстропрогрессирующий нефритический синдромгломерулонефритгепатит Сcryoglobulinemic vasculitisrapidly progressive nephritic syndromeglomerulonephritishepatitis CReferencesФерри К. Смешанная криоглобулинеми. Нефрология 2010; 14 (1)Ферри К. Смешанная криоглобулинеми. Нефрология 2010; 14 (1)Barry M. Brenner , «Brenner and Rector’s The Kidney» , 8th ed. Saunders 2007, chapter 32Barry M. Brenner , «Brenner and Rector’s The Kidney» , 8th ed. Saunders 2007, chapter 32D’Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54: 650–671D’Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54: 650–671Perico N, Cattaneo D, Bikbov, B, Remuzzi G. Hepatitis C Infection and Chronic Renal Diseases. Clin J Am Soc Nephrol 2009; 4: 207-220Perico N, Cattaneo D, Bikbov, B, Remuzzi G. Hepatitis C Infection and Chronic Renal Diseases. Clin J Am Soc Nephrol 2009; 4: 207-220Meyers CM, Seeff LB, Stehman-Breen C O, Hoofnagle JH. Hepatitis C and renal disease: an update, American Journal of Kidney Diseases 2003; 42( 4) 631-657Meyers CM, Seeff LB, Stehman-Breen C O, Hoofnagle JH. Hepatitis C and renal disease: an update, American Journal of Kidney Diseases 2003; 42( 4) 631-657Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47: 618-623Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47: 618-623Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465–470Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465–470Garini G, Allegri L, Iannuzzella F, et al. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapie. Acta Biomed 2007; 78: 51-59Garini G, Allegri L, Iannuzzella F, et al. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapie. Acta Biomed 2007; 78: 51-59Sinico RA, Fornasieri A, D’Amico G. Renal manifestations associated with hepatitis C virus. Ann Med Interne 2000; 151(1): 41-45Sinico RA, Fornasieri A, D’Amico G. Renal manifestations associated with hepatitis C virus. Ann Med Interne 2000; 151(1): 41-45Saadoun D, Delluc A, Piette JC, Cacoub P. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Current Opinion in Rheumatology 2008; 20: 23–28Saadoun D, Delluc A, Piette JC, Cacoub P. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Current Opinion in Rheumatology 2008; 20: 23–28Cacoub P, Delluc A, Saadoun D, et al. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand. Ann Rheum Dis 2008; 67: 283-287Cacoub P, Delluc A, Saadoun D, et al. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand. Ann Rheum Dis 2008; 67: 283-287Милованова СЮ, Лопаткина ТН, Козловская ЛВ, Краснова ТН. Моноклональные антитела к B-лимфоцитам (ритуксимаб) в лечении HCV-ассоциированного криоглобулинемического гломерулонефрита тяжелого течения. Тер арх 2007; 6: 69-72Милованова СЮ, Лопаткина ТН, Козловская ЛВ, Краснова ТН. Моноклональные антитела к B-лимфоцитам (ритуксимаб) в лечении HCV-ассоциированного криоглобулинемического гломерулонефрита тяжелого течения. Тер арх 2007; 6: 69-72Forde KA, Reddy KR. Hepatitis C Virus Infection and Immunomodulatory Therapies. Clinics in Liver Disease 2009; 13(3): 391-401Forde KA, Reddy KR. Hepatitis C Virus Infection and Immunomodulatory Therapies. Clinics in Liver Disease 2009; 13(3): 391-401Fabrizi F, Lunghi G, Messa P, Martin P. Therapy of hepatitis C virus–associated glomerulonephritis: current approaches. J Nephrol 2008; 21: 813-825Fabrizi F, Lunghi G, Messa P, Martin P. Therapy of hepatitis C virus–associated glomerulonephritis: current approaches. J Nephrol 2008; 21: 813-825Roccatello D, Fornasieri A, Giachino O, et al. Multicenter Study on Hepatitis C Virus–Related Cryoglobulinemic Glomerulonephritis. Am J Kidney Dis 2007; 49(1): 69-82Roccatello D, Fornasieri A, Giachino O, et al. Multicenter Study on Hepatitis C Virus–Related Cryoglobulinemic Glomerulonephritis. Am J Kidney Dis 2007; 49(1): 69-82Ramos-Casals M, Robles A, Brito-Zerуn P, et al. Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum 2006; 36(3): 189-196Ramos-Casals M, Robles A, Brito-Zerуn P, et al. Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum 2006; 36(3): 189-196Ahmed MS, Wong CF, Shawki H, et al. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature. Clin Nephrol 2008; 69(4): 298-301Ahmed MS, Wong CF, Shawki H, et al. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature. Clin Nephrol 2008; 69(4): 298-301Ohta S, Yokoyama H, Wada T et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis 1999; 33(6): 1040-1048Ohta S, Yokoyama H, Wada T et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis 1999; 33(6): 1040-1048Bruchfeld A, Lindahl K, Stеhle L, et al. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 2003; 18(8): 1573-1580Bruchfeld A, Lindahl K, Stеhle L, et al. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 2003; 18(8): 1573-1580McHutchison JG, Manns MP, Brown RS Jr, et al. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. Am J Gastroenterol 2007; 102(4): 880-889McHutchison JG, Manns MP, Brown RS Jr, et al. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. Am J Gastroenterol 2007; 102(4): 880-889Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 49(4): 1335-1374Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 49(4): 1335-1374Rossini A, Ravaggi A, Biasi L et al. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis. Hepatology 1997; 26(4): 1012-1017Rossini A, Ravaggi A, Biasi L et al. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis. Hepatology 1997; 26(4): 1012-1017Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: Patients with normal aminotransferase levels.Hepatology 1997; 26[Suppl1]:133S-136SMarcellin P, Levy S, Erlinger S. Therapy of hepatitis C: Patients with normal aminotransferase levels.Hepatology 1997; 26[Suppl1]:133S-136SJamal MM, Soni A, Quinn PG et al. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United States. Hepatology 1999; 30(5): 1307-1311Jamal MM, Soni A, Quinn PG et al. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United States. Hepatology 1999; 30(5): 1307-1311http: //consensus.nih.gov/2002/2002HepatitisC2002116html.htmhttp: //consensus.nih.gov/2002/2002HepatitisC2002116html.htm

The authors declare that there are no conflicts of interest present.